{"lastModified":"2026-05-07T22:00:45","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=16424","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DT6CYD","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/16424/body","rel":"body"}],"num":16424,"receiptDate":"2026-04-07","term":10,"title":"Interpelacja w sprawie dostępności produktu leczniczego Nimotop oraz obowiązujących zasad jego refundacji na terenie Rzeczypospolitej Polskiej","answerDelayedDays":0,"from":["472"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2026-04-15"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDTUJ2W/i16424-o1.pdf","lastModified":"2026-05-07T22:00:45","name":"i16424-o1.pdf"}],"from":"Podsekretarz stanu Katarzyna Anna Kacperczyk","key":"DTUJ2W","lastModified":"2026-05-07T22:00:45","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DTUJ2W","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/16424/reply/DTUJ2W/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2026-04-30"}],"sentDate":"2026-04-15","to":["minister zdrowia"]}